TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients
Shenzhen TargetRx Co., Ltd.
Shenzhen TargetRx Co., Ltd.
Novartis
Ascentage Pharma Group Inc.
Il-Yang Pharm. Co., Ltd.
Il-Yang Pharm. Co., Ltd.
Eastern Cooperative Oncology Group
Shenzhen Second People's Hospital
Children's Oncology Group
Shenzhen Second People's Hospital
Takeda
Takeda
Institut Bergonié
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Masonic Cancer Center, University of Minnesota
Hamad Medical Corporation
First Affiliated Hospital of Harbin Medical University
Heidelberg University
Newcastle University
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
Alliance for Clinical Trials in Oncology
Bristol-Myers Squibb
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Il-Yang Pharm. Co., Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Novartis
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Vanderbilt-Ingram Cancer Center
Northwestern University
Fred Hutchinson Cancer Center
Novartis
Tufts Medical Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center